Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Dose”

450 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 450 results

Not applicableUnknownNCT01855737
What this trial is testing

The Study of Warfarin Maintenance Dose in Chinese Patients

Who this might be right for
Atrial FibrillationHeart Valve DiseasePulmonary Artery Embolism
Chinese Academy of Medical Sciences, Fuwai Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00368056
What this trial is testing

Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

Who this might be right for
Primary Insomnia
Sumitomo Pharma America, Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT00689052
What this trial is testing

Pramipexole ER vs. Placebo in Fibromyalgia

Who this might be right for
Fibromyalgia
Boehringer Ingelheim 61
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Testing effectiveness (Phase 2)Study completedNCT00048035
What this trial is testing

Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 91
Early research (Phase 1)Active Not RecruitingNCT06671444
What this trial is testing

Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment

Who this might be right for
InsomniaRenal Impairment
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT00317226
What this trial is testing

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Who this might be right for
Anemia
American Regent, Inc. 145
Post-approval studies (Phase 4)Not Yet RecruitingNCT06257316
What this trial is testing

Appropriate Dosage of Vasopressor in Neonates and Infants

Who this might be right for
HypotensionNeonatal HypotensionIntraoperative Complications
Seoul National University Hospital 132
Testing effectiveness (Phase 2)Study completedNCT00005948
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT02468284
What this trial is testing

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Testing effectiveness (Phase 2)UnknownNCT03719664
What this trial is testing

Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects

Who this might be right for
HIV-1-infection
Frontier Biotechnologies Inc. 80
Large-scale testing (Phase 3)Study completedNCT02163499
What this trial is testing

Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months

Who this might be right for
Hyperkalemia
ZS Pharma, Inc. 751
Post-approval studies (Phase 4)Study completedNCT00362193
What this trial is testing

Glycemic Relapse Prevention: Maintenance Dose Assessment

Who this might be right for
Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 165
Testing effectiveness (Phase 2)Study completedNCT00266344
What this trial is testing

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

Who this might be right for
Primary Insomnia
H. Lundbeck A/S 520
Early research (Phase 1)Study completedNCT00798395
What this trial is testing

Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

Who this might be right for
Sleep Initiation and Maintenance DisordersMental Disorders
Merck Sharp & Dohme LLC 32
Large-scale testing (Phase 3)Study completedNCT02088073
What this trial is testing

Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.

Who this might be right for
Hyperkalemia
ZS Pharma, Inc. 258
Post-approval studies (Phase 4)Looking for participantsNCT06169371
What this trial is testing

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Who this might be right for
Breast Cancer
University of Illinois at Chicago 50
Large-scale testing (Phase 3)UnknownNCT03010202
What this trial is testing

The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ostfold Hospital Trust 136
Large-scale testing (Phase 3)Active Not RecruitingNCT04337450
What this trial is testing

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Who this might be right for
HIV Infections
PENTA Foundation 386
Load More Results